Literature DB >> 26633957

"Fold Here"-Chemical Correctors in the Treatment of Epilepsy.

Adam L Hartman.   

Abstract

Entities:  

Year:  2015        PMID： 26633957      PMCID： PMC4657770          DOI： 10.5698/1535-7511-15.6.340

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  9 in total

1.  Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features.

Authors:  Sergey Kalachikov; Oleg Evgrafov; Barbara Ross; Melodie Winawer; Christie Barker-Cummings; Filippo Martinelli Boneschi; Chang Choi; Pavel Morozov; Kamna Das; Elita Teplitskaya; Andrew Yu; Eftihia Cayanis; Graciela Penchaszadeh; Andreas H Kottmann; Timothy A Pedley; W Allen Hauser; Ruth Ottman; T Conrad Gilliam
Journal:  Nat Genet       Date:  2002-01-28       Impact factor: 38.330

Review 2.  Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.

Authors:  Rebecca S Pettit
Journal:  Ann Pharmacother       Date:  2012-06-26       Impact factor: 3.154

3.  Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission.

Authors:  Yuko Fukata; Hillel Adesnik; Tsuyoshi Iwanaga; David S Bredt; Roger A Nicoll; Masaki Fukata
Journal:  Science       Date:  2006-09-22       Impact factor: 47.728

Review 4.  New and emerging HDAC inhibitors for cancer treatment.

Authors:  Alison C West; Ricky W Johnstone
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

Review 5.  Inhibitors of histone deacetylase as new anticancer agents.

Authors:  M Jung
Journal:  Curr Med Chem       Date:  2001-10       Impact factor: 4.530

6.  Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy.

Authors:  José M Morante-Redolat; Ana Gorostidi-Pagola; Salomé Piquer-Sirerol; Amets Sáenz; Juan J Poza; Juan Galán; Stefan Gesk; Theologia Sarafidou; Victor-F Mautner; Simona Binelli; Eike Staub; Bernd Hinzmann; Lisa French; Jean-F Prud'homme; Daniela Passarelli; Paolo Scannapieco; Carlo A Tassinari; Giuliano Avanzini; José F Martí-Massó; Lan Kluwe; Panagiotis Deloukas; Nicholas K Moschonas; Roberto Michelucci; Reiner Siebert; Carlo Nobile; Jordi Pérez-Tur; Adolfo López de Munain
Journal:  Hum Mol Genet       Date:  2002-05-01       Impact factor: 6.150

7.  Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy.

Authors:  Norihiko Yokoi; Yuko Fukata; Daisuke Kase; Taisuke Miyazaki; Martine Jaegle; Toshika Ohkawa; Naoki Takahashi; Hiroko Iwanari; Yasuhiro Mochizuki; Takao Hamakubo; Keiji Imoto; Dies Meijer; Masahiko Watanabe; Masaki Fukata
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

8.  LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures.

Authors:  Wenli Gu; Eylert Brodtkorb; Ortrud K Steinlein
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

9.  Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency.

Authors:  S W Brusilow; J Finkelstien
Journal:  Metabolism       Date:  1993-10       Impact factor: 8.694
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.